fda warning letters compounding semaglutide september 2025 Beyond the Headlines: to GLP-1 Compounders FDA warns Ozempic and Mounjaro

While Wegovy is approved specifically for weight management, Ozempic is also used for treating type 2 diabetes

However, you might notice the effect of lower hunger wearing off after 4-5 days post-injection in the first month of taking Wegovy

The next developments are expected to be triple agonists and oligos

For continuation versus noncontinuation, the weighted prevalence ratios were 1.29 (95 percent confidence interval, 0.82 to 2.06), 1.08 (95 percent confidence interval, 0.84 to 1.40), and 1.21 (95 percent confidence interval, 0.83 to 1.82) for small for gestational age, large for gestational age, and MCM, respectively."Accumulated evidence provides some reassurance about risk for malformations after inadvertent exposure in women who become pregnant while using GLP-1 RAs," the authors write.Abstract/Full Text (subscription or payment may be required).Sign up for our weekly HealthDay newsletter

Name on a label contents in a vial